Neuraxis Inc

Research Neuraxis Inc (NRXS) on Bullrun: market cap USD 88.42M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNRXS
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 88.42M
• Financial periodFY2025
• RevenueUSD 3.57M
• Revenue growth32.9%
• Net income-USD 7.80M
• Free cash flow-USD 6.46M
• Gross margin84.2%

Valuation Snapshot

latest market cap is USD 88.42M.

About Neuraxis Inc

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms.

Frequently asked questions

What is Neuraxis Inc's market cap?

Neuraxis Inc's market capitalization is USD 88.42M.

What does Neuraxis Inc do?

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.